| Reading
Room
The PILOT™ Reading Room provides a practical synopsis of recently
published articles by PILOT™ Steering Committee members and other
distinguished faculty. Each summary includes a link for retrieval
of the article abstract.
August 2008 - Article Summary
Read a commentary by Charlie Strange, MD, of the Medical University of South Carolina, on the clinical implications of the publication
by Rosas IO, et al (PLoS Med. 2008;5(4):e93.)
entitled "MMP1 and MMP7 as potential peripheral blood biomarkers in idiopathic pulmonary fibrosis."
Click here for expert commentary on this article.
June 2008 - Article Summary
Read a commentary by Paul W. Noble, MD, FCCP, of the Duke University School of Medicine, Durham, North Carolina, on the clinical implications of the publication
by Lawson WE, et al (Thorax. 2004;59:977-980.)
entitled "Genetic mutations in surfactant protein C are a rare cause of sporadic cases of IPF."
Click here for expert commentary on this article.
March 2008 - Article Summary
Read a commentary by Harold R. Collard, MD, of the University of California, San Francisco on the clinical implications of the publications
by Jastrzebski D, et al (J Physiol Pharmacol. 2006;57(Suppl 4):139-148.)
entitled "Dyspnea and quality of life in patients with pulmonary fibrosis after six weeks of respiratory rehabilitation," as well as
Naji NA, et al (J Cardiopulm Rehabil. 2006;26(4):237-243.)
entitled "Effectiveness of pulmonary rehabilitation in restrictive lung disease."
Click here for expert commentary on this article.
February 2008 - Article Summary
Read a commentary by Glenn D. Rosen, MD, of Stanford University School of Medicine, on the clinical implications of the publication
by King TE Jr, Behr J, Brown KK, et al (Am J Respir Crit Care Med. 2008;177(1):75-81.)
entitled "BUILD-1: A randomized placebo-controlled trial of bosentan in patients with idiopathic pulmonary fibrosis."
Click here for expert commentary on this article.
December 2007 - Article Summary
Read a commentary by Paul W. Noble, MD, of Duke University School of Medicine, on the clinical implications of the publication
by Demedts M, et al (N Engl J Med. 2005;353(21):2229-2242.)
entitled "High-Dose Acetylcysteine in Idiopathic Pulmonary Fibrosis."
Click here for expert commentary on this article.
October 2007 - Article Summary
Read a commentary by Jeffrey A. Golden, MD, of the University of California at San Francisco, on the clinical implications of the publication
by Collard HR, et al (Am J Respir Crit Care Med. June 21, 2007.)
entitled "Pulmonary Perspective: Acute Exacerbations of Idiopathic Pulmonary Fibrosis."
Click here for expert commentary on this article.
July 2007 - Article Summary
Read a commentary by Harold R. Collard, MD, of the University of California, San Francisco on the clinical implications of the publication
by Nathan SD, et al (Am J Respir Crit Care Med. 2007;175:875-880.)
entitled "Idiopathic Pulmonary Fibrosis and Pulmonary Hypertension: Connecting the Dots."
Click here for expert commentary on this article.
March 2007 - Article Summary
Read a commentary by Steven A. Sahn, MD, of the Medical University
of South Carolina on the clinical implications of the publication
by Collard HR, et al (Respir Med. 2006, doi:10.1016/j.rmed.2006.10.002.)
entitled "Patient Experiences With Pulmonary Fibrosis."
Click here for expert commentary on this article.
December 2006 - Article Summary
Read a commentary by Timothy Whelan, MD, of the University of Minnesota
School of Medicine on the clinical implications of the publication
by Lynch DA, et al (Radiology. 2005;236:10-21) entitled "Idiopathic
Interstitial Pneumonias: CT Features."
Click here for expert commentary on
this article.
November 2006 - Article Summary
Read a commentary by Harold R. Collard, MD, of the University of
California, San Francisco on the clinical implications of the publication
by Flaherty KR, et al (Am J Respir Crit Care Med. 2006;174:803-809)
entitled "Idiopathic Pulmonary Fibrosis: Prognostic Value of Changes
in Physiology and Six-Minute-Walk Test."
Click here for expert commentary on
this article.
October 2006 - Article Summary
Read a commentary by Maria L. Padilla, MD, of the Mount Sinai School
of Medicine on the clinical implications of the publication by Lederer
DJ, et al (Am J Transplant. 2006;6:398-403) entitled "Racial
and Ethnic Disparities in Survival in Lung Transplant Candidates
with Idiopathic Pulmonary Fibrosis."
Click here for expert commentary on this
article.
September 2006 - Article Summary
Read a commentary by Steven D. Nathan, MD, of the Inova Fairfax
Hospital on the clinical implications of the publication by Kim
DS, et al (Eur Respir J. 2006;27:143-150) entitled "Acute
Exacerbations of Idiopathic Pulmonary Fibrosis: Frequency and Clinical
Features."
Click here for expert commentary on this article.
August 2006 - Article Summary
Read a commentary by Steven A. Sahn, MD, of the Medical University
of South Carolina on the clinical implications of the publication
by Martinez FJ, et al, for the IPF Study Group. (Ann Intern Med.
2005;142:963-967) entitled "The Clinical Course of Patients with
Idiopathic Pulmonary Fibrosis."
Click here for expert commentary on this article.
June 2006 - Article Summary
Read a commentary by Glenn D. Rosen, MD, of Stanford University
on the clinical implications of the publication by Flaherty et al
(Am J Respir Crit Care Med. 2004;170:904-910) entitled "Idiopathic
Interstitial Pneumonia: What Is the Effect of a Multidisciplinary
Approach to Diagnosis?"
Click here for expert commentary on this article.
|
